Clinical trial
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy: A Multicenter, Randomized, Controlled, Open-Label Study
NCT07276919 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy: A Multicenter, Randomized, Controlled, Open-Label Study
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- January 1, 2028
- Enrollment
- 1,844 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute urinary retention, luts(lower urinary tract symptoms)